Toni L. Ripley

712 total citations
29 papers, 493 citations indexed

About

Toni L. Ripley is a scholar working on Cardiology and Cardiovascular Medicine, Geriatrics and Gerontology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Toni L. Ripley has authored 29 papers receiving a total of 493 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Cardiology and Cardiovascular Medicine, 7 papers in Geriatrics and Gerontology and 6 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Toni L. Ripley's work include Pharmaceutical Practices and Patient Outcomes (7 papers), Heart Failure Treatment and Management (6 papers) and Blood Pressure and Hypertension Studies (5 papers). Toni L. Ripley is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (7 papers), Heart Failure Treatment and Management (6 papers) and Blood Pressure and Hypertension Studies (5 papers). Toni L. Ripley collaborates with scholars based in United States, Belgium and Canada. Toni L. Ripley's co-authors include Joseph J. Saseen, Jeremy L. Johnson, Susan E. Conway, Donald L. Harrison, Karen McConnell, Udho Thadani, Sarah McBane, John M. Burke, Joseph P. Vande Griend and Lawrence J. Cohen and has published in prestigious journals such as American Journal of Psychiatry, The American Journal of the Medical Sciences and Clinical Therapeutics.

In The Last Decade

Toni L. Ripley

28 papers receiving 471 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Toni L. Ripley United States 11 130 121 106 79 62 29 493
Dawn E. Havrda United States 12 78 0.6× 50 0.4× 90 0.8× 64 0.8× 62 1.0× 33 384
Kristin Weitzel United States 19 157 1.2× 76 0.6× 222 2.1× 33 0.4× 89 1.4× 32 1.2k
Heather P. Whitley United States 14 60 0.5× 62 0.5× 114 1.1× 53 0.7× 79 1.3× 40 554
Amy M. Franks United States 16 51 0.4× 97 0.8× 164 1.5× 74 0.9× 81 1.3× 48 659
Dana G. Carroll United States 12 156 1.2× 63 0.5× 64 0.6× 18 0.2× 46 0.7× 38 597
J. Chris Bradberry United States 12 77 0.6× 34 0.3× 79 0.7× 29 0.4× 41 0.7× 20 382
Mary J. Ferrill United States 15 70 0.5× 57 0.5× 159 1.5× 62 0.8× 85 1.4× 26 667
Beth Bryles Phillips United States 13 108 0.8× 297 2.5× 93 0.9× 22 0.3× 81 1.3× 35 651
Lucas Van Bortel Belgium 14 197 1.5× 159 1.3× 53 0.5× 20 0.3× 62 1.0× 33 768
Michael E. Pitterle United States 22 324 2.5× 31 0.3× 138 1.3× 98 1.2× 145 2.3× 46 1.1k

Countries citing papers authored by Toni L. Ripley

Since Specialization
Citations

This map shows the geographic impact of Toni L. Ripley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Toni L. Ripley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Toni L. Ripley more than expected).

Fields of papers citing papers by Toni L. Ripley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Toni L. Ripley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Toni L. Ripley. The network helps show where Toni L. Ripley may publish in the future.

Co-authorship network of co-authors of Toni L. Ripley

This figure shows the co-authorship network connecting the top 25 collaborators of Toni L. Ripley. A scholar is included among the top collaborators of Toni L. Ripley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Toni L. Ripley. Toni L. Ripley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Rathbun, R. Chris, et al.. (2016). Propofol-associated QTc prolongation. Therapeutic Advances in Drug Safety. 7(3). 68–78. 11 indexed citations
3.
Finks, Shannon W. & Toni L. Ripley. (2015). Sorting It Out: What JNC 8 Is and What It Is Not. Journal of Managed Care & Specialty Pharmacy. 21(2). 110–112. 4 indexed citations
4.
Ripley, Toni L., et al.. (2015). Controversies Among the Hypertension Guidelines. Journal of Pharmacy Practice. 29(1). 5–14. 2 indexed citations
5.
Ripley, Toni L., Michael Brenner, Shannon W. Finks, et al.. (2015). Key Articles and Guidelines in the Management of Hypertension. Journal of Pharmacy Practice. 28(2). 146–161. 2 indexed citations
6.
Ripley, Toni L. & Joseph J. Saseen. (2014). β-Blockers. Annals of Pharmacotherapy. 48(6). 723–733. 66 indexed citations
7.
Liedtke, Michelle D., et al.. (2014). Incidence of Transmitted Antiretroviral Drug Resistance in Treatment-Naive HIV-1-Infected Persons in a Large South Central United States Clinic. Annals of Pharmacotherapy. 48(4). 470–475. 10 indexed citations
8.
Smith, Marcus J., et al.. (2012). Warfarin Management Using Point-of-Care Testing in a University-Based Internal Medicine Resident Clinic. The American Journal of the Medical Sciences. 344(4). 289–293. 5 indexed citations
9.
Ripley, Toni L., et al.. (2012). An Intervention to Increase Safety Feature Use on Smart Pumps: A Quality Improvement Initiative. Journal of Pharmacy Technology. 28(3). 119–123. 2 indexed citations
10.
Ripley, Toni L., et al.. (2012). Impact of a clinical pharmacist on a cardiovascular surrogate endpoint: a pilot study. Pharmacy Practice. 10(3). 173–179. 5 indexed citations
11.
Dunn, Rebecca L., Donald L. Harrison, & Toni L. Ripley. (2011). The Beers Criteria As an Outpatient Screening Tool for Potentially Inappropriate Medications. The Consultant Pharmacist. 26(10). 754–763. 14 indexed citations
12.
Germany, Robin & Toni L. Ripley. (2010). Controversies in Cardiac Resynchronization Therapy: Do Sex Differences in Response Exist?. Current Heart Failure Reports. 8(1). 59–64. 3 indexed citations
13.
Conway, Susan E., Jeremy L. Johnson, & Toni L. Ripley. (2010). Integration of Team-Based Learning Strategies Into a Cardiovascular Module. American Journal of Pharmaceutical Education. 74(2). 35–35. 87 indexed citations
14.
Ripley, Toni L., Donald L. Harrison, Robin Germany, & Philip B. Adamson. (2010). Effect of heart failure exacerbations on anticoagulation: A prospective, observational, pilot cohort study. Clinical Therapeutics. 32(3). 506–514. 6 indexed citations
15.
Denus, Simon de, et al.. (2008). Key Articles and Guidelines in the Management of Hypertension: 2008 Update. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 28(8). 1041–1058. 9 indexed citations
16.
Thadani, Udho & Toni L. Ripley. (2007). Side effects of using nitrates to treat heart failure and the acute coronary syndromes, unstable angina and acute myocardial infarction. Expert Opinion on Drug Safety. 6(4). 385–396. 22 indexed citations
17.
Ripley, Toni L., et al.. (2006). Candesartan in heart failure. Clinical Interventions in Aging. 1(4). 357–366. 13 indexed citations
18.
Ripley, Toni L.. (2005). Valsartan in Chronic Heart Failure. Annals of Pharmacotherapy. 39(3). 460–469. 10 indexed citations
19.
Ripley, Toni L., Dawn E. Havrda, Steve M. Blevins, & Daniel J. Culkin. (2004). Early Evaluation of Hematuria in a Patient Receiving Anticoagulant Therapy and Detection of Malignancy. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 24(11). 1638–1640. 5 indexed citations
20.
Ripley, Toni L., et al.. (1989). Dr. Koczapski and Associates Reply. American Journal of Psychiatry. 146(9). 1235–a. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026